Summary. The roles of diabetes mellitus, insulin-like growth factor I and insulin in vascular smooth muscle proliferation in vivo were studied. Proliferation was induced by endothelial injury (balloon catheterization) of rat aorta, and was measured as 3H-thymidine incorporation into DNA. Levels of insulin-like growth factor I mRNA and insulin-like growth factor I receptor mRNA were measured with a solution hybridization assay. The increase in DNA synthesis was most pronounced 2 days after injury in both normal and diabetic rats and declined there after, but DNA synthesis in aortas from diabetic rats was lower throughout the time period studied. Levels of insulin-like growth factor I mRNA and the receptor mRNA were both increased in balloon catheterized aortas, and time-course studies showed an increase in receptor mRNA prior to the increase in insulin-like growth factor I mRNA. Diabetic rats were treated with equimolar concentrations of insulin (35 nmol/day) or insulin-like growth factor I (31 nmol/day) for 5 days. Insulin-like growth factor I increased DNA synthesis in injured aortas 2 days after injury without improving blood glucose, whereas the effect of insulin was associated with a decrease in blood glucose levels. In conclusion, vascular smooth muscle proliferation is impaired by diabetes and stimulated by insulin treatment. Insulin-like growth factor I infusion stimulates vascular smooth muscle proliferation without affecting bloo glucose, and gene expressions of insulin-like growth factor I and its receptor are increased in proliferating vascular smooth muscle, indicating that insulin-like growth factor I is involved in vascular smooth muscle proliferation in vivo.
Atherosclerotic disease is a main cause of morbidity and mortality in patients with diabetes mellitus. Insulin has been suggested to have a direct role in the development of atherosclerosis by stimulating proliferation of vascular smooth muscle cells [1] . The receptors for insulin and insulin-like growth factor I (IGF-I) are homologous [2] . The fact that high insulin concentrations are required to stimulate DNA synthesis and interact with the IGF-I receptor suggests that these effects could be mediated by IGF-I receptors [3, 4] . IGF-I in nanomolar concentrations stimulates proliferation of vascular smooth muscle cells in vitro [3, 4] , although the mitogenic effect of IGF-I alone is weak compared to the effects of platelet-derived growth factor and basic fibroblast growth factor [5, 6] . However, the growth-promoting effects of IGF-I, and high concentrations of insulin, have been found to be additive to the effects of other growth factors [7] . Thus, IGF-I and insulin may act in concert with other growth factors to stimulate vascular smooth muscle proliferation in vivo. These considerations prompted the present study to investigate the roles of insulin and IGF-I in vascular smooth muscle proliferation in normal and diabetic rats in vivo.
Materials and methods

Animals
Male rats (300 g) of the Sprague-Dawley strain (ALAB, Stockholm, Sweden) were kept under a 12 h light: 12 h darkness cycle (light from 07.00 to 19.00 hours). Diabetes was induced by i. v. injection of streptozotocin (65 mg/kg body weight) in a tail vein; control rats were injected with 0.9% NaC1. Diabetic rats were treated with insulin (Actrapid Human 35 nmol/day = 5 U/day; Novo Nordisk, Copenhagen, Denmark) or recombinant human IGF-I (31 nmol/day) via osmotic minipumps for 5 days (3 days before de-endothelialization and 2 days after). The osmotic pumps (Alzet; Alza Corp., Palo Alto, Calif., USA) were placed subcutaneously over the thoracic spine. Normal rats and diabetic rats treated with 0.9% NaCI served as controls. De-endothelialization according to the method of Capron et al. [8] was performed after a diabetes duration of 2 weeks. In short, the rats were kept under light ether anaesthesia and a deflated embolectomy catheter (Fogarty, size 2F; Baxter International Inc., Santa Ana, Cafif., USA) was introduced into the aorta through the left common carotid artery down to the level of the renal arteries. The balloon was inflated with 40-50 gl distilled water, and withdrawn to the level of the diaphragm where it was inflated with an additional 20-30 gl of distilled water. This procedure was repeated twice and the carotid artery was then double ligated. Selection of the rat prior to catheterization was performed randomly to avoid bias. Shamoperated control rats were treated in the same way but the catheter was not introduced into the aorta. To study re-endothelialization, rats were anaesthetized with Ketalar (Parke-Davies, Barcelona, Spain) and Rompun (Bayer AG, Leverkusen, FRG) and 2 ml Evans blue (0.5%) was injected into a tail vein. After 30 min the aortas were prepared, cleaned, examined and photographed. White spots were considered to represent areas covered with endothelial cells. Body weights of the rats were measured daily at 10.00 hours, and blood glucose was measured twice daily using a hexokinase method (Gluco-quant; Boehringer-Mannheim, Mannheim, FRG).
Measurement of DNA synthesis
After 0, 1, 2, 7 and 14 days, rats were anaesthetized with ether, the aortic segment between the left subclavian artery and the celiac artery was removed, opened longitudinally, and transferred into 2 ml of Krebs-Henseleit bicarbonate buffer according to Capron et al. [8] . DNA synthesis in the intima-media was measured as 3H-thymidine incorporation during i h incubation, and DNA was purified from proteins and RNA according to Hutchison and Munro [11] .
Measurement of lGF-I mRNA and IGF-I receptor mRNA
Levels of IGF-I mRNA and IGF-I receptor mRNA were measured in the intima-media from normal rats. The rats were killed by an overdose of ether, the aorta dissected into theintima-media and adventitia layers and the intima-media layer was frozen in liquid nitrogen. Intima-medias from two normal rats were pooled in each sample. The intima-medias were homogenized in a sodium-dodecyl sulphate-containing buffer with a glass-glass homogenizer for approximately 30 s. The samples were digested with proteinase K (Merck, Darmstadt, FRG) and then extracted with phenol and chloroform. Total nucleic acid (TNA) was precipitated by addition of ethanol, and DNA content was measured by fluorimetry [12] . Levels of IGF-I mRNA were analysed using a 35S-UTP labelled RNA probe complementary to 153 base pairs in exon 3 of the mouse IGF-I gene [13] , and a 265 bases rat IGF-I receptor RNA probe complementary to part of the 5'untranslated sequence and sequences encoding the signal peptide and the first 53 amino acids of the IGF-I receptor c~-subunit [14] was used to measure IGF-I receptor mRNA. Solution hybridization was performed as described previously [15] . In short, the probes were hybridized to TNA samples at 70~ for 16 h. The samples was then exposed to RNases and the hybrids subsequently precipitated with tfichloroacetic acid and collected on glass-micro fibre filters. The radioactivity of the samples was measured in a liquid scintillation counter and compared with that of a standard curve constructed from incubation with a rat liver TNA sample with a known amount of IGF-I mRNA or a synthetic standard of IGF-I receptor mRNA.
Statistical analysis
Values are given as mean + SEM. Levels of significance were calculated by using analysis of variance.
Measurements of serum insulin and IGF-I
Serum levels of insulin and IGF-I were measured with radioimmunoassays. Since IGF-binding proteins interact with the IGF-I radioimmunoassay, serum IGF-I was separated from IGF-binding proteins according to a modified method of Philipps et al. [9] . Serum (75 gl) was acidified and diluted to 360 gl with acetic acid (final concentration 2 tool/l), and then incubated at 4~ overnight. IGF-I was separated from binding proteins on a 50 x 1.0 cm Sephadex G50 (fine) column (Pharmacia Fine Chemicals, Uppsala, Sweden) equilibrated in 0.1 mol/1 acetic acid, and a flow rate of 1.5-2.0 ml/h. The columns were calibrated with dextran blue, cytochromeC (Mr = 12.5 kilodaltons) and 125I-IGF-I (Amersham International plc, Amersham, Bucks, UK). The separation of the binding protein peak and the IGF-I peak on a Sephadex G50 column is illustrated in Figure 1 . Less than 5% of ~25I-IGF-I pre-incubated with serum at neutral pH for 24 h was still associated with binding proteins after acidification and chromatography. Fractions containing free IGF-I were pooled and lyophilized. IGF-I was measured with radioimmunoassay as described [10] , using recombinant human IGF-I as standard. The recovery when recombinant IGF-I was incubated with a serum sample, acidified, separated on columns, lyophilized and measured was 99.9 _+ 12.0% (n = 4). Serum insulin was measured with Phadeseph insulin radioimmunoassay kit (Pharmacia Diagnostics, Uppsala, Sweden) based on a double antibody technique.
Results
Time course ofD NA synthesis
The time courses of 3H-thymidine incorporation into DNA (estimated as DNA specific activity, cpm/gg DNA) in normal and diabetic rats were similar as shown in Figure 2 . A peak in DNA synthesis was seen 2 days after injury, and a decline was evident between day 2 and day 7. However, the DNA synthesis in aortas from diabetic rats was lower than in aortas from normal rats throughout the time period studied. DNA specific activity in sham-operated animals was similar day 0 and day 14, but sham-operated diabetic rats had a lower specific activity than normal rats (Fig. 2) .
The DNA content 2weeks after injury was 85.4+4.0gg DNA/aorta (n =4) in normal rats and 59.2 + 1.7 gg DNA/aorta in diabetic rats (n = 4; p < 0.001 when analysed with two-tailed Student's t-test for unpaired observations). The DNA content in sham-operated control rats was 62.8 + 2.1 gg DNA/aorta (n = 3) 2 weeks after sham-operation. Time (days) Fig.2 . Time-course studies of DNA synthesis in intima-media after balloon catheterization of normal rats ( 9 ) and diabetic rats ( 9 ) . Balloon catheterization was performed on day 0. Sham-operated rats are marked with squares (N, 9 ). Values are presented as mean _+ SEM (injured rats, n = 4; sham-operated normal rats day 14, n = 3; sham-operated diabetic rats and normal rats day 0, n = 2)
K. E. Bornfeldt et al.: Proliferation of vascular smooth muscle in vivo the injury more than half of the aorta was re-endothelialized (data not shown). No differences between nondiabetic and diabetic rats were found either in shamoperated rats, or 2, 7 or 14 days after endothelial injury (data not shown).
Time course of lGF-I mRNA and IGF-I receptor mRNA
Levels of IGF-I mRNA in intima-media from normal rats were mcreased 49.2 + 0.1% 2 days after injury, and the time course of the increase was associated with increase in DNA synthesis (Fig. 3 a) . The levels of IGF-I mRNA in shamtreated rats were similar before the operation and 14 days after the operation (Fig.3 a) . Levels of IGF-I receptor mRNA were increased at an earlier time-point after injury compared with IGF-I mRNA (52.2 + 7.6% increase i day after injury), and declined 14 days after injury (Fig. 3 b) . Fig.3a, b . Time-course studies of levels of insulin-like growth factor I (IGF-I) mRNA (a) and IGF-I receptor mRNA (b) in intima-media after balloon catheterization of normal rats ( 9 ) . Balloon catheterization was performed on day 0. Sham-operated rats are marked with squares ( 9 Values are presented as mean a(lxl0-1S)mol mRNA/gg DNA + SEM (injured rats, n = 4; sham-operated normal rats day 14, n = 3; sham-operated normal rats day 0, n = 2)
Effect of insulin and IGF-I on DNA synthesis in diabetic rats
Evans blue staining
Two days after injury the balloon catheterized aortas were completely blue when compared with aortas from sham-operated rats. Seven days after the injury, white spots, representing re-endothelialized areas, had appeared around the intercostal arteries, and 2 weeks after Treatment of diabetic rats with insulin (35 nmol/day) or IGF-I (31nmol/day) during 5days increased body weights 33+2g (from 252+7g) and 18_+3g (from 245 + 9 g), respectively. Body weights of diabetic rats treated with 0.9% NaCt were unchanged (3 _+ 1 g, from 244+7g), whereas the non-diabetic rats increased 11 + 2 g (from 321 + 4 g) during the 5-day period. Insulin decreased, but did not normalize, blood glucose levels (32.6 + 1.2 to 19.9 + 1.7 mmol/1), whereas IGF-I did not affect blood glucose levels of the diabetic rats at all (31.3 + 1.0 to 30.4 + 1.6 mmol/1). Blood glucose of normal rats was 7.1 + 0.1 mmol/1 at the end of the treatment period. Serum levels of insulin and IGF-I are shown in Table 1 .
Both insulin and IGF-I increased DNA synthesis in injured aortas from diabetic rats (Fig. 4) , but DNA synthesis did not reach the level found in normal rats. Values are presented as mean+SEM. DNA-specific activity was 939 +46 cpm/gg DNA in injured aortas from normal rats and 225 + 48 cprrdgg DNA in sham-operated normal rats (n = 4). Thepvalue was less than 0.001 when injured insulin-treated diabetic rats and injured untreated diabetic rats were compared, as well as when injured IGF-I-treated diabetic rats and injured-untreated diabetic rats were compared using analysis of variance
Discussion
The results of the present study show that DNA synthesis after endothelial injury is impaired by diabetes. In previous studies addressing this issue, no difference in DNA synthesis [8] or the size of the intimal lesions [16] after endothelial injury was found when diabetic and non-diabetic rats were compared. The contradictory results may be due to the use of a different strain of rats in these studies (Wistar rats), or the different duration of diabetes. Another explanation may be that the severity of the diabetic state is important for vascular smooth muscle proliferation in diabetic rats, since both of the previous studies used lower doses of streptozotocin (40-45 mg/kg body weight) than that used in the present study (65 mg/kg body weight). Recently, it was reported that fasting decreases DNA synthesis after endothelial injury [17] . Fasting, like diabetes, is characterized by low levels of insulin and IGF-I, and the mechanisms responsible for the decreased DNA synthesis during fasting and severe diabetes may be similar. Treatment of diabetic rats with insulin for 5 days lowered blood glucose, improved the diabetic state and increased DNA synthesis. These effects of insulin indicate that the impaired DNA synthesis during untreated diabetes is due the diabetic state per se and not to a toxic effect of streptozotocin. Although the diabetic rats treated with insulin were clearly hyperinsulinaemic at the end of the experiment, DNA synthesis was not increased to the level found in non-diabetic rats. It may be speculated that the effect of insulin on DNA synthesis is not direct, but due to general improvement of the diabetic state. Part of the effect of insulin may be mediated by IGF-I since insulin infusion normalized serum levels of IGF-I. IGF-I increased DNA synthesis without affecting blood glucose levels. The effect of IGF-I is probably due to stimulation of IGF-I receptors in vascular smooth muscle, 107 and a direct effect of IGF-I on DNA synthesis has previously been shown in cultured vascular smooth muscle cells [3, 4] . However, it can not be excluded that IGF-I is also important for metabolism in the vascular wall. Several metabolic parameters [18] , and levels of IGF-I mRNA are markedly decreased in rat aorta by diabetes and fasting [15] . Both metabolic states obviously can result in an impaired proliferation of the vascular smooth muscle cells.
Infused IGF-I has recently been found to increase DNA synthesis in thymocytes from diabetic rats despite persisting hyperglycaemia [19] , which indicates that circulating IGF-I is able to increase proliferation in various tissues in vivo. The results of the present study show that levels of IGF-I receptor mRNA may be increased before the well-documented increase in DNA synthesis after endothelial injury [8, 20] . An increased expression of IGF-I receptors should result in an enhanced effect of circulating, but also locally produced, IGF-I on the vascular smooth muscle cells, and increased IGF-I immunoreactivity has previously been demonstrated in the vascular wall after endothelial injury [21] . The increased levels of IGF-I mRNA in vascular smooth muscle after endothelial injury demonstrated in the present study, and in a recent study [22] , indicate that IGF-I may also have autocrine effects during vascular smooth muscle proliferation in vivo.
In conclusion, IGF-I is involved in proliferation of vascular smooth muscle in vivo.
